Αναζήτηση
Αποτελέσματα 1-8 από 8
Acute Renal Failure: A Rare Presentation of Hypothyroidism
(2009)
Thyroid hormones affect the function of almost every body organ, and thyroid dysfunction produces a wide range of metabolic disturbances. Severe hypothyroidism is associated with significant effects on the kidney. The ...
Renal physiology in elderly persons with severe immobility syndrome
(2009)
The immobility syndrome (IS) is a common condition in the elderly and consists of a reduction in the capacity to perform daily activities because of motor function deterioration. This syndrome leads to characteristic ...
Dexamethasone decreases the transmesothelial electrical resistance of the parietal and visceral pleura
(2009)
The effect of dexamethasone on the transmesothelial electrical resistance (R (TM)) of sheep pleura was investigated by Ussing chamber experiments. Our results show that dexamethasone decreases the R (TM) of sheep pleurae, ...
Effect of cimetidine on the electrophysiologic profile of isolated visceral sheep peritoneum
(2009)
The peritoneal mesothelium is a barrier to ion transport in peritoneal dialysis. Cimetidine is an H2 receptor antagonist and a potent inhibitor of Na+/H+ antiporter, which is found in the plasma membranes of various cell ...
The Role of Hepcidin in Iron Homeostasis and Anemia in Hemodialysis Patients
(2009)
Anemia is a common complication in hemodialysis (HD) patients. Despite the great success of recombinant human erythropoietin in clinical practice, resistance to this therapy is common. Additionally, nephrologists frequently ...
PATIENT SELECTION FOR AUTOMATED PERITONEAL DIALYSIS: FOR WHOM, WHEN?
(2009)
The use of the various forms of automated peritoneal dialysis (APD) has increased considerably in the past few years. This increase has in part been driven by technology, through improved cycler design. Other contributing ...
Spironolactone increases permeability of visceral sheep peritoneum
(2009)
Aldosterone is a key component of the renin-angiotensin-aldosterone system, and spironolactone, an aldosterone receptor blocker, shows beneficial effects in patients with end-stage renal disease and heart failure. The aim ...